TapewireFind a company

person · Reporting owner

Karp Carol D.

Disclosed activity across 1 company

Tapewire entity
82243
SEC CIK
0001692214

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
PROTHENA CORP PUBLIC LTD COPRTA · Entity 2375Chief Regulatory OfficerMarch 05, 2025March 07, 2025

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

PROTHENA CORP PUBLIC LTD CO

Report date March 05, 2025 · Filed March 07, 2025

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $14.95 · Expires 2035-03-05Direct107,500 Reported balance After 2025-03-05 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2025-03-05 · Grant · Acquired 107,500 · Balance 107,500

F1: The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on March 5, 2026, and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.

Filing footnotes · ownership attribution and instrument terms

F1: The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on March 5, 2026, and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
March 05, 2025 Filed Mar 7, 2025 16:28 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 GrantStock Option (Right to Buy) · Derivative 107,500 $0.00 Strike: $14.95 $0.00
Disclosure

SEC source: 0000905148-25-000882 · form4.xml · derivative · entry 1

Karp Carol D. · CIK 0001692214 · Chief Regulatory Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 107,500

Underlying: Ordinary Shares · 107,500 shares

Expires 2035-03-05

F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on March 5, 2026, and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.

Read SEC document
February 27, 2024 Filed Feb 29, 2024 21:02 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 GrantStock Option (Right to Buy) · Derivative 85,000 $0.00 Strike: $30.30 $0.00
Disclosure

SEC source: 0000905148-24-000835 · form4.xml · derivative · entry 1

Karp Carol D. · CIK 0001692214 · Chief Regulatory Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 85,000

Underlying: Ordinary Shares · 85,000 shares

Expires 2034-02-27

F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on February 27, 2025, and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.

Read SEC document
October 04, 2023 Filed Oct 4, 2023 19:52 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 Exercise / conversionStock Option (Right to Buy) · Derivative 5,000 $0.00 Strike: $12.15 $0.00
Disclosure

SEC source: 0000905148-23-001091 · form4.xml · derivative · entry 4

Karp Carol D. · CIK 0001692214 · Chief Regulatory Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 45,000

Underlying: Ordinary Shares · 5,000 shares

Expires 2030-02-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The shares subject to the option vested and became exercisable as to 25% of the total number of shares subject to the option on February 25, 2021, and vest and become exercisable with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.

Read SEC document
October 04, 2023 Filed Oct 4, 2023 19:52 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 SaleOrdinary Shares, par value $0.01 per share 663 $47.29 $31,355.26
Disclosure

SEC source: 0000905148-23-001091 · form4.xml · nonDerivative · entry 3

Karp Carol D. · CIK 0001692214 · Chief Regulatory Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2023.

F3 · price: The transaction was executed in multiple trades in prices ranging from $47.23 to $47.40, inclusive.

Read SEC document
October 04, 2023 Filed Oct 4, 2023 19:52 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 SaleOrdinary Shares, par value $0.01 per share 4,337 $46.51 $201,729.05
Disclosure

SEC source: 0000905148-23-001091 · form4.xml · nonDerivative · entry 2

Karp Carol D. · CIK 0001692214 · Chief Regulatory Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 663

F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2023.

F2 · price: The transaction was executed in multiple trades in prices ranging from $45.86 to $46.78, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the ranges set forth in footnotes 2 through 3 of this Form 4.

Read SEC document
October 04, 2023 Filed Oct 4, 2023 19:52 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 Exercise / conversionOrdinary Shares, par value $0.01 per share 5,000 $12.15 $60,750.00
Disclosure

SEC source: 0000905148-23-001091 · form4.xml · nonDerivative · entry 1

Karp Carol D. · CIK 0001692214 · Chief Regulatory Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 06, 2023 Filed Sep 6, 2023 19:42 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 Exercise / conversionStock Option (Right to Buy) · Derivative 5,000 $0.00 Strike: $12.15 $0.00
Disclosure

SEC source: 0000905148-23-000853 · form4.xml · derivative · entry 4

Karp Carol D. · CIK 0001692214 · Chief Regulatory Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Ordinary Shares · 5,000 shares

Expires 2030-02-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The shares subject to the option vested and became exercisable as to 25% of the total number of shares subject to the option on February 25, 2021, and vest and become exercisable with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.

Read SEC document
September 06, 2023 Filed Sep 6, 2023 19:42 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 SaleOrdinary Shares, par value $0.01 per share 6 $55.27 $331.62
Disclosure

SEC source: 0000905148-23-000853 · form4.xml · nonDerivative · entry 3

Karp Carol D. · CIK 0001692214 · Chief Regulatory Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2023.

Read SEC document
September 06, 2023 Filed Sep 6, 2023 19:42 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 SaleOrdinary Shares, par value $0.01 per share 4,994 $54.76 $273,471.94
Disclosure

SEC source: 0000905148-23-000853 · form4.xml · nonDerivative · entry 2

Karp Carol D. · CIK 0001692214 · Chief Regulatory Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 6

F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2023.

F2 · price: This transaction was executed in multiple trades in prices ranging from $54.23 to $55.20, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in footnote 2 of this Form 4.

Read SEC document
September 06, 2023 Filed Sep 6, 2023 19:42 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 Exercise / conversionOrdinary Shares, par value $0.01 per share 5,000 $12.15 $60,750.00
Disclosure

SEC source: 0000905148-23-000853 · form4.xml · nonDerivative · entry 1

Karp Carol D. · CIK 0001692214 · Chief Regulatory Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 02, 2023 Filed Aug 2, 2023 21:00 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 Exercise / conversionStock Option (Right to Buy) · Derivative 5,000 $0.00 Strike: $12.15 $0.00
Disclosure

SEC source: 0001140361-23-037712 · form4.xml · derivative · entry 4

Karp Carol D. · CIK 0001692214 · Chief Regulatory Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 55,000

Underlying: Ordinary Shares · 5,000 shares

Expires 2030-02-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The shares subject to the option vested and became exercisable as to 25% of the total number of shares subject to the option on February 25, 2021, and vest and become exercisable with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.

Read SEC document
August 02, 2023 Filed Aug 2, 2023 21:00 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 SaleOrdinary Shares, par value $0.01 per share 328 $67.95 $22,288.09
Disclosure

SEC source: 0001140361-23-037712 · form4.xml · nonDerivative · entry 3

Karp Carol D. · CIK 0001692214 · Chief Regulatory Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2023.

F3 · price: The transaction was executed in multiple trades in prices ranging from $67.63 to $68.61, inclusive.

Read SEC document
August 02, 2023 Filed Aug 2, 2023 21:00 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 SaleOrdinary Shares, par value $0.01 per share 4,672 $66.95 $312,783.86
Disclosure

SEC source: 0001140361-23-037712 · form4.xml · nonDerivative · entry 2

Karp Carol D. · CIK 0001692214 · Chief Regulatory Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 328

F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2023.

F2 · price: The transaction was executed in multiple trades in prices ranging from $66.46 to $67.33, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the ranges set forth in footnotes 2 through 3 of this Form 4.

Read SEC document
August 02, 2023 Filed Aug 2, 2023 21:00 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 Exercise / conversionOrdinary Shares, par value $0.01 per share 5,000 $12.15 $60,750.00
Disclosure

SEC source: 0001140361-23-037712 · form4.xml · nonDerivative · entry 1

Karp Carol D. · CIK 0001692214 · Chief Regulatory Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 05, 2023 Filed Jul 5, 2023 21:33 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 Exercise / conversionStock Option (Right to Buy) · Derivative 5,000 $0.00 Strike: $12.15 $0.00
Disclosure

SEC source: 0001140361-23-033193 · form4.xml · derivative · entry 4

Karp Carol D. · CIK 0001692214 · Chief Regulatory Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 60,000

Underlying: Ordinary Shares · 5,000 shares

Expires 2030-02-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The shares subject to the option vested and became exercisable as to 25% of the total number of shares subject to the option on February 25, 2021, and vest and become exercisable with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.

Read SEC document
July 05, 2023 Filed Jul 5, 2023 21:33 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 SaleOrdinary Shares, par value $0.01 per share 1,034 $68.69 $71,027.42
Disclosure

SEC source: 0001140361-23-033193 · form4.xml · nonDerivative · entry 3

Karp Carol D. · CIK 0001692214 · Chief Regulatory Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2023.

F3 · price: The transaction was executed in multiple trades in prices ranging from $68.44 to $68.99, inclusive.

Read SEC document
July 05, 2023 Filed Jul 5, 2023 21:33 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 SaleOrdinary Shares, par value $0.01 per share 3,966 $67.98 $269,608.68
Disclosure

SEC source: 0001140361-23-033193 · form4.xml · nonDerivative · entry 2

Karp Carol D. · CIK 0001692214 · Chief Regulatory Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,034

F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2023.

F2 · price: The transaction was executed in multiple trades in prices ranging from $67.385 to $68.38, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the ranges set forth in footnotes 2 through 3 of this Form 4.

Read SEC document
July 05, 2023 Filed Jul 5, 2023 21:33 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 Exercise / conversionOrdinary Shares, par value $0.01 per share 5,000 $12.15 $60,750.00
Disclosure

SEC source: 0001140361-23-033193 · form4.xml · nonDerivative · entry 1

Karp Carol D. · CIK 0001692214 · Chief Regulatory Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 07, 2023 Filed Jun 7, 2023 21:49 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 Exercise / conversionStock Option (Right to Buy) · Derivative 15,000 $0.00 Strike: $13.53 $0.00
Disclosure

SEC source: 0001140361-23-028869 · form4.xml · derivative · entry 8

Karp Carol D. · CIK 0001692214 · Chief Regulatory Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 35,000

Underlying: Ordinary Shares · 15,000 shares

Expires 2029-02-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: The shares subject to the option vested and became exercisable as to 25% of the total number of shares subject to the option on February 27, 2020, and vest and become exercisable with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.

Read SEC document
June 07, 2023 Filed Jun 7, 2023 21:49 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 Exercise / conversionStock Option (Right to Buy) · Derivative 5,000 $0.00 Strike: $12.15 $0.00
Disclosure

SEC source: 0001140361-23-028869 · form4.xml · derivative · entry 7

Karp Carol D. · CIK 0001692214 · Chief Regulatory Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 65,000

Underlying: Ordinary Shares · 5,000 shares

Expires 2030-02-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: The shares subject to the option vested and became exercisable as to 25% of the total number of shares subject to the option on February 25, 2021, and vest and become exercisable with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.

Read SEC document
June 07, 2023 Filed Jun 7, 2023 21:49 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 SaleOrdinary Shares, par value $0.01 per share 361 $72.93 $26,327.73
Disclosure

SEC source: 0001140361-23-028869 · form4.xml · nonDerivative · entry 6

Karp Carol D. · CIK 0001692214 · Chief Regulatory Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2023.

F5 · price: The transaction was executed in multiple trades in prices ranging from $72.545 to $73.14, inclusive.

Read SEC document
June 07, 2023 Filed Jun 7, 2023 21:49 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 SaleOrdinary Shares, par value $0.01 per share 3,811 $71.97 $274,270.81
Disclosure

SEC source: 0001140361-23-028869 · form4.xml · nonDerivative · entry 5

Karp Carol D. · CIK 0001692214 · Chief Regulatory Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 361

F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2023.

F4 · price: The transaction was executed in multiple trades in prices ranging from $71.53 to $72.41, inclusive.

Read SEC document
June 07, 2023 Filed Jun 7, 2023 21:49 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 SaleOrdinary Shares, par value $0.01 per share 12,782 $71.00 $907,495.16
Disclosure

SEC source: 0001140361-23-028869 · form4.xml · nonDerivative · entry 4

Karp Carol D. · CIK 0001692214 · Chief Regulatory Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,172

F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2023.

F3 · price: The transaction was executed in multiple trades in prices ranging from $70.53 to $71.51, inclusive.

Read SEC document
June 07, 2023 Filed Jun 7, 2023 21:49 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 SaleOrdinary Shares, par value $0.01 per share 3,046 $69.90 $212,915.70
Disclosure

SEC source: 0001140361-23-028869 · form4.xml · nonDerivative · entry 3

Karp Carol D. · CIK 0001692214 · Chief Regulatory Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 16,954

F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 7, 2023.

F2 · price: The transaction was executed in multiple trades in prices ranging from $69.53 to $70.52, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the ranges set forth in footnotes 2 through 5 of this Form 4.

Read SEC document
June 07, 2023 Filed Jun 7, 2023 21:49 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 Exercise / conversionOrdinary Shares, par value $0.01 per share 15,000 $13.53 $202,950.00
Disclosure

SEC source: 0001140361-23-028869 · form4.xml · nonDerivative · entry 2

Karp Carol D. · CIK 0001692214 · Chief Regulatory Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 20,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 07, 2023 Filed Jun 7, 2023 21:49 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 Exercise / conversionOrdinary Shares, par value $0.01 per share 5,000 $12.15 $60,750.00
Disclosure

SEC source: 0001140361-23-028869 · form4.xml · nonDerivative · entry 1

Karp Carol D. · CIK 0001692214 · Chief Regulatory Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 02, 2023 Filed Mar 3, 2023 21:31 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 GrantStock Option (Right to Buy) · Derivative 48,000 $0.00 Strike: $52.97 $0.00
Disclosure

SEC source: 0001140361-23-010186 · form4.xml · derivative · entry 1

Karp Carol D. · CIK 0001692214 · Chief Regulatory Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 48,000

Underlying: Ordinary Shares · 48,000 shares

Expires 2033-03-02

F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on March 2, 2024 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.

Read SEC document
February 23, 2022 Filed Feb 25, 2022 21:32 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 GrantStock Option (Right to Buy) · Derivative 85,000 $0.00 Strike: $32.45 $0.00
Disclosure

SEC source: 0001140361-22-006899 · form4.xml · derivative · entry 1

Karp Carol D. · CIK 0001692214 · Chief Regulatory Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,000

Underlying: Ordinary Shares · 85,000 shares

Expires 2032-02-23

F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on February 23, 2023 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.

Read SEC document
November 01, 2021 Filed Nov 3, 2021 21:17 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 Exercise / conversionStock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $15.04 $0.00
Disclosure

SEC source: 0001567619-21-019301 · doc1.xml · derivative · entry 5

Karp Carol D. · CIK 0001692214 · Chief Regulatory Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 120,000

Underlying: Ordinary Shares · 10,000 shares

Expires 2028-06-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The shares subject to the option vest and become exercisable as to 25% of the total number of shares subject to the option on June 21, 2019 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.

Read SEC document
November 01, 2021 Filed Nov 3, 2021 21:17 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 SaleOrdinary Shares, par value $0.01 per share 4,937 $58.51 $288,854.00
Disclosure

SEC source: 0001567619-21-019301 · doc1.xml · nonDerivative · entry 4

Karp Carol D. · CIK 0001692214 · Chief Regulatory Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F4 · price: The transaction was executed in multiple trades in prices ranging from $58.14 to $58.76, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
November 01, 2021 Filed Nov 3, 2021 21:17 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 SaleOrdinary Shares, par value $0.01 per share 2,725 $56.65 $154,379.15
Disclosure

SEC source: 0001567619-21-019301 · doc1.xml · nonDerivative · entry 3

Karp Carol D. · CIK 0001692214 · Chief Regulatory Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,937

F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F3 · price: The transaction was executed in multiple trades in prices ranging from $56.185 to $56.89, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
November 01, 2021 Filed Nov 3, 2021 21:17 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 SaleOrdinary Shares, par value $0.01 per share 2,338 $55.00 $128,585.32
Disclosure

SEC source: 0001567619-21-019301 · doc1.xml · nonDerivative · entry 2

Karp Carol D. · CIK 0001692214 · Chief Regulatory Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,662

F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2 · price: The transaction was executed in multiple trades in prices ranging from $54.92 to $55.16, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
November 01, 2021 Filed Nov 3, 2021 21:17 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 Exercise / conversionOrdinary Shares, par value $0.01 per share 10,000 $15.04 $150,400.00
Disclosure

SEC source: 0001567619-21-019301 · doc1.xml · nonDerivative · entry 1

Karp Carol D. · CIK 0001692214 · Chief Regulatory Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 01, 2021 Filed Oct 1, 2021 20:46 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 Exercise / conversionStock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $15.04 $0.00
Disclosure

SEC source: 0001140361-21-033345 · form4.xml · derivative · entry 7

Karp Carol D. · CIK 0001692214 · Chief Regulatory Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 130,000

Underlying: Ordinary Shares · 10,000 shares

Expires 2028-06-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on June 21, 2019 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.

Read SEC document
October 01, 2021 Filed Oct 1, 2021 20:46 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 SaleOrdinary Shares, par value $0.01 per share 213 $70.44 $15,003.72
Disclosure

SEC source: 0001140361-21-033345 · form4.xml · nonDerivative · entry 6

Karp Carol D. · CIK 0001692214 · Chief Regulatory Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

Read SEC document
October 01, 2021 Filed Oct 1, 2021 20:46 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 SaleOrdinary Shares, par value $0.01 per share 2,600 $69.61 $180,996.92
Disclosure

SEC source: 0001140361-21-033345 · form4.xml · nonDerivative · entry 5

Karp Carol D. · CIK 0001692214 · Chief Regulatory Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 213

F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F5 · price: The transaction was executed in multiple trades in prices ranging from $69.33 to $70.115, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
October 01, 2021 Filed Oct 1, 2021 20:46 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 SaleOrdinary Shares, par value $0.01 per share 1,967 $68.68 $135,084.91
Disclosure

SEC source: 0001140361-21-033345 · form4.xml · nonDerivative · entry 4

Karp Carol D. · CIK 0001692214 · Chief Regulatory Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,813

F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F4 · price: The transaction was executed in multiple trades in prices ranging from $68.33 to $69.13, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
October 01, 2021 Filed Oct 1, 2021 20:46 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 SaleOrdinary Shares, par value $0.01 per share 2,620 $67.98 $178,097.91
Disclosure

SEC source: 0001140361-21-033345 · form4.xml · nonDerivative · entry 3

Karp Carol D. · CIK 0001692214 · Chief Regulatory Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,780

F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F3 · price: The transaction was executed in multiple trades in prices ranging from $67.33 to $68.30, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
October 01, 2021 Filed Oct 1, 2021 20:46 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 SaleOrdinary Shares, par value $0.01 per share 2,600 $66.60 $173,152.46
Disclosure

SEC source: 0001140361-21-033345 · form4.xml · nonDerivative · entry 2

Karp Carol D. · CIK 0001692214 · Chief Regulatory Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,400

F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2 · price: The transaction was executed in multiple trades in prices ranging from $66.29 to $67.035, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
October 01, 2021 Filed Oct 1, 2021 20:46 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 Exercise / conversionOrdinary Shares, par value $0.01 per share 10,000 $15.04 $150,400.00
Disclosure

SEC source: 0001140361-21-033345 · form4.xml · nonDerivative · entry 1

Karp Carol D. · CIK 0001692214 · Chief Regulatory Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 09, 2021 Filed Sep 10, 2021 17:06 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 Exercise / conversionStock Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $15.04 $0.00
Disclosure

SEC source: 0001140361-21-030941 · form4.xml · derivative · entry 4

Karp Carol D. · CIK 0001692214 · Chief Regulatory Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 140,000

Underlying: Ordinary Shares · 10,000 shares

Expires 2028-06-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on June 21, 2019 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.

Read SEC document
September 09, 2021 Filed Sep 10, 2021 17:06 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 SaleOrdinary Shares, par value $0.01 per share 4,542 $72.63 $329,885.01
Disclosure

SEC source: 0001140361-21-030941 · form4.xml · nonDerivative · entry 3

Karp Carol D. · CIK 0001692214 · Chief Regulatory Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F3 · price: The transaction was executed in multiple trades in prices ranging from $72.16 to $72.83, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
September 09, 2021 Filed Sep 10, 2021 17:06 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 SaleOrdinary Shares, par value $0.01 per share 5,458 $71.45 $389,961.55
Disclosure

SEC source: 0001140361-21-030941 · form4.xml · nonDerivative · entry 2

Karp Carol D. · CIK 0001692214 · Chief Regulatory Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,542

F1 · kind: The transactions reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2 · price: The transaction was executed in multiple trades in prices ranging from $70.94 to $71.75, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Read SEC document
September 09, 2021 Filed Sep 10, 2021 17:06 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 Exercise / conversionOrdinary Shares, par value $0.01 per share 10,000 $15.04 $150,400.00
Disclosure

SEC source: 0001140361-21-030941 · form4.xml · nonDerivative · entry 1

Karp Carol D. · CIK 0001692214 · Chief Regulatory Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 25, 2021 Filed Feb 26, 2021 17:10 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 GrantStock Option (Right to Buy) · Derivative 56,000 $0.00 Strike: $22.60 $0.00
Disclosure

SEC source: 0001567619-21-005082 · doc1.xml · derivative · entry 1

Karp Carol D. · CIK 0001692214 · Chief Regulatory Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,000

Underlying: Ordinary Shares · 56,000 shares

Expires 2031-02-25

F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on February 25, 2022 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.

Read SEC document
February 12, 2021 Filed Feb 17, 2021 18:39 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 GrantEmployee Stock Option (Right to Buy) · Derivative 45,112 Not disclosed Strike: $22.85 Not disclosed
Disclosure

SEC source: 0001567619-21-004307 · doc1.xml · derivative · entry 4

Karp Carol D. · CIK 0001692214 · Chief Regulatory Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,112

Underlying: Ordinary Shares · 45,112 shares

Expires 2028-02-21

F4 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 60,000 of the issuer's ordinary shares granted to the reporting person on February 21, 2018. In exchange, the reporting person received a replacement option, for 45,112 ordinary shares, having an exercise price of $22.85 per ordinary share.

F5 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 47/48 of the total number of shares subject to the option on the one year anniversary of the date of grant and with respect to 1/48 of the total number of shares subject to the option on February 21, 2022, subject to the reporting person's continued service with the issuer on each such vesting date.

Read SEC document
February 12, 2021 Filed Feb 17, 2021 18:39 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative 60,000 Not disclosed Strike: $33.10 Not disclosed
Disclosure

SEC source: 0001567619-21-004307 · doc1.xml · derivative · entry 3

Karp Carol D. · CIK 0001692214 · Chief Regulatory Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 60,000 shares

Expires 2028-02-21

F4 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 60,000 of the issuer's ordinary shares granted to the reporting person on February 21, 2018. In exchange, the reporting person received a replacement option, for 45,112 ordinary shares, having an exercise price of $22.85 per ordinary share.

F3 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on February 21, 2019 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the reporting person's continued employment with the issuer on each such vesting date.

Read SEC document
February 12, 2021 Filed Feb 17, 2021 18:39 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 GrantEmployee Stock Option (Right to Buy) · Derivative 51,282 Not disclosed Strike: $22.85 Not disclosed
Disclosure

SEC source: 0001567619-21-004307 · doc1.xml · derivative · entry 2

Karp Carol D. · CIK 0001692214 · Chief Regulatory Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,282

Underlying: Ordinary Shares · 51,282 shares

Expires 2026-12-14

F1 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 100,000 of the issuer's ordinary shares granted to the reporting person on December 14, 2016. In exchange, the reporting person received a replacement option, for 51,282 ordinary shares, having an exercise price of $22.85 per ordinary share.

F2 · derivative.exercise_date: The shares subject to the option will vest and become exercisable on the one year anniversary of the date of grant, subject to the reporting person's continued service with the issuer through such one year anniversary.

Read SEC document
February 12, 2021 Filed Feb 17, 2021 18:39 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative 100,000 Not disclosed Strike: $52.78 Not disclosed
Disclosure

SEC source: 0001567619-21-004307 · doc1.xml · derivative · entry 1

Karp Carol D. · CIK 0001692214 · Chief Regulatory Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Ordinary Shares · 100,000 shares

Expires 2026-12-14

F1 · price: On February 12, 2021, the issuer canceled, pursuant to the issuer's option exchange program, an option for 100,000 of the issuer's ordinary shares granted to the reporting person on December 14, 2016. In exchange, the reporting person received a replacement option, for 51,282 ordinary shares, having an exercise price of $22.85 per ordinary share.

Read SEC document
February 25, 2020 Filed Feb 27, 2020 17:18 UTC PROTHENA CORP PUBLIC LTD CO PRTA · Entity 2375 GrantStock Option (Right to Buy) · Derivative 70,000 $0.00 Strike: $12.15 $0.00
Disclosure

SEC source: 0001567619-20-005020 · doc1.xml · derivative · entry 1

Karp Carol D. · CIK 0001692214 · Chief Regulatory Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,000

Underlying: Ordinary Shares · 70,000 shares

Expires 2030-02-25

F1 · derivative.exercise_date: The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on February 25, 2021 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment with the Issuer on each such vesting date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.